Siemens Claims A First With Test That Can Quantify Neutralizing Antibodies To COVID-19

The test measures the relative level of antibodies, which could aid vaccine rollout.

Medical doctor or laborant holding tube with covid vaccine and microscope. Coronavirus 2019-nCoV COVID concept.

Siemens Healthineers AG has CE marked a SARS-CoV-2 IgG antibody test, which it claims is the first diagnostic from a major IVD company to measure the quantity of neutralizing antibodies. This will be important in measuring the effectiveness of COVID-19 vaccines and determining whether broad vaccination programs are working. The company has submitted the test to the US Food and Drug Administration under an emergency use authorization.

There are numerous quantitative tests for SARS-CoV-2 antibodies available, but Siemens Healthineers claims other quantitative tests from major suppliers do not measure neutralizing antibodies. The sCOVG test detects antibodies that...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Business